These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 32010931)
1. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects. Zhang S; Jiang J; Tang W; Liu L Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931 [TBL] [Abstract][Full Text] [Related]
2. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study. Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048 [TBL] [Abstract][Full Text] [Related]
3. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Sun H; Han B; Zhai H; Cheng X; Ma K Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589 [TBL] [Abstract][Full Text] [Related]
4. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis. Wang B; Ma M; Guo X; Yan Y; Li L Medicine (Baltimore); 2021 Oct; 100(41):e27527. PubMed ID: 34731145 [TBL] [Abstract][Full Text] [Related]
5. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker. Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187 [TBL] [Abstract][Full Text] [Related]
6. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population. Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382 [TBL] [Abstract][Full Text] [Related]
7. The association between MTHFR gene polymorphisms and hepatocellular carcinoma risk: a meta-analysis. Qin X; Peng Q; Chen Z; Deng Y; Huang S; Xu J; Li H; Li S; Zhao J PLoS One; 2013; 8(2):e56070. PubMed ID: 23457501 [TBL] [Abstract][Full Text] [Related]
8. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Jin F; Qu LS; Shen XZ Diagn Pathol; 2009 Nov; 4():39. PubMed ID: 19930673 [TBL] [Abstract][Full Text] [Related]
9. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation. Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200 [TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study. Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480 [TBL] [Abstract][Full Text] [Related]
11. Correlation Between Su H Nutr Cancer; 2019; 71(7):1055-1060. PubMed ID: 31282757 [TBL] [Abstract][Full Text] [Related]
12. Correlation between Methylenetetrahydrofolate Reductase Polymorphisms and Hepatocellular Carcinoma: A Meta-Analysis. Su H; Zhang G Ann Nutr Metab; 2019; 74(3):251-256. PubMed ID: 30917367 [TBL] [Abstract][Full Text] [Related]
13. Significant association between the MTHFR A1298C polymorphism and hepatocellular carcinoma risk: a meta-analysis. Chang W; Meng Q; Liu JH; Wu LX; Chen Y; Chen SD Genet Mol Res; 2015 Dec; 14(4):15972-80. PubMed ID: 26662389 [TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma. Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043 [TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314 [TBL] [Abstract][Full Text] [Related]
17. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma]. Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414 [TBL] [Abstract][Full Text] [Related]
18. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma. Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease. Zhu ZG; Ai QL; Wang WM; Xiao ZC Gene; 2013 Nov; 531(1):78-83. PubMed ID: 23916622 [TBL] [Abstract][Full Text] [Related]
20. Association between Tan X; Chen H Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]